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Abstract We recently reported the results of a genome-
wide association study (GWAS) of schizophrenia in the
Japanese population. In that study, a single nucleotide
polymorphism (SNP) (rs3106653) in the KCNJ3 (potas-
sium inwardly rectifying channel, subfamily J, member 3)
gene located at 2q24.1 showed association with schizo-
phrenia in two independent sample sets. KCNJ3, also
termed GIRK1 or Kir3.1, is a member of the G protein-
activated inwardly rectifying K
? channel (GIRK) group.
GIRKs are widely distributed in the brain and play an
important role in regulating neural excitability through the
activation of various G protein-coupled receptors. In this
study, we set out to examine this association using a dif-
ferent population. We ﬁrst performed a gene-centric asso-
ciation study of the KCNJ3 gene, by genotyping 38
tagSNPs in the Chinese population. We detected nine SNPs
that displayed signiﬁcant association with schizophrenia
(lowest P = 0.0016 for rs3106658, Global signiﬁ-
cance = 0.036). The initial marker SNP (rs3106653)
examined in our prior GWAS in the Japanese population
also showed nominally signiﬁcant association in the Chi-
nese population (P = 0.028). Next, we analyzed transcript
levels in the dorsolateral prefrontal cortex of postmortem
brains from patients with schizophrenia and bipolar disor-
der and from healthy controls, using real-time quantitative
RT-PCR. We found signiﬁcantly lower KCNJ3 expression
in postmortem brains from schizophrenic and bipolar
patients compared with controls. These data suggest that
the KCNJ3 gene is genetically associated with schizo-
phrenia in Asian populations and add further evidence to
the ‘‘channelopathy theory of psychiatric illnesses’’.
Abbreviations
GWAS Genome-wide association study
SNP Single nucleotide polymorphism
KCNJ3 Potassium inwardly rectifying channel,
subfamily J, member 3
GIRK G protein-activated inwardly rectifying K
?
channel
GPCRs G protein-coupled receptors
GABA c-Aminobutyric acid
PMI Postmortem interval
LD Linkage disequilibrium
HWE Hardy–Weinberg equilibrium
SE Standard error
NMDA N-methyl-D-aspartate
Introduction
Schizophrenia is a highly heritable neurodevelopmental
disorder, with a complex pathophysiology. It is thought
that multiple susceptibility genes, each with a small effect,
act in conjunction with epigenetic processes and environ-
mental factors. Identifying these susceptibility genes is still
challenging and the underlying mechanisms of disease
remain largely elusive.
In a search for schizophrenia susceptibility genes, we
recently carried out a whole genome association survey and
replication study, analyzing two sets of samples from
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DOI 10.1007/s00439-011-1089-3Japanese cohorts. This approach revealed novel candidate
genes associated with schizophrenia in the Japanese popu-
lation (Yamada et al. 2011). Among the top hit signals in
the two-stage association analyses, the KCNJ3 gene drew
special attention because several other genome-wide
association studies (GWASs) (O’Donovan et al. 2009; Tam
et al. 2010; Williams et al. 2011) and gene expression
studies (Arion and Lewis 2011; Bigos et al. 2010; Huffaker
et al. 2009; Kalkman 2011) of schizophrenia and other
psychiatric illnesses have revealed a potential role in dis-
ease etiology for ion channel genes. Genes for calcium
channel [CACNA1C: calcium channel, voltage-dependent,
L type, alpha 1C subunit], potassium channels [KCNE1:
potassium voltage-gated channel, Isk-related family,
member 1, KCNE2: potassium voltage-gated channel,
Isk-related family, member 2, KCNH2: potassium voltage-
gated channel, subfamily H (eag-related), member 2] and
chloride transporters [NKCC1: sodium/potassium/chloride
cotransporter 1, also known as SLC12A2 (solute carrier
family 12, member 2), KCC2: potassium/chloride co-
transporter 2, also known as SLC12A5 (solute carrier
family 12, member 5)] have emerged from these studies.
However, the role of the KCNJ3 gene in schizophrenia
pathogenesis has not been evaluated so far.
KCNJ3, also known as GIRK1/Kir3.1, belongs to the
family of G protein-gated inwardly rectifying potassium
(GIRK/Kir3) channels. GIRK channels play an important
role in controlling neuronal excitability, by generating slow
inhibitory potentials, following the activation of G protein-
coupled receptors (GPCRs). These GPCRs, are in turn
stimulated by various neurotransmitters, such as dopamine,
serotonin, opioids and c-aminobutyric acid (GABA). The
involvement of these neurotransmitters and cognate GPCRs
in schizophrenia has been suggested by multiple lines of
evidence (Karam et al. 2010). GIRK channels are also
implicated in the pathophysiology of several other diseases,
such as epilepsy, addiction, Down’s syndrome, ataxia and
Parkinson’s disease (Luscher and Slesinger 2010). There-
fore, it is tempting to speculate that any of these systems
related to GIRK channels may contribute to the psychiatric
symptoms and cognitive defects seen in schizophrenia.
To corroborate the association of KCNJ3 with schizo-
phrenia in Asian populations, we examined the gene using
the following approaches: (1) we performed gene-centric
analyses using tag SNPs that span the entire KCNJ3 gene
region to achieve greater coverage of genetic variations; (2)
we resequenced and analyzed the coding region of the
gene; (3) we analyzed patient–parent pedigrees of Chinese
descent, an ethnically similar but different population (Kim
et al. 2005; Tian et al. 2008); (4) we performed an
expression study of the gene using postmortem brains from
patients with schizophrenia and bipolar disorder and from
controls.
Materials and methods
Samples
Chinese samples consisted of 293 pedigrees (1,163 sub-
jects: 9 trios and 284 quads) collected by the NIMH ini-
tiative (http://nimhgenetics.org/).
RNA from the dorsolateral prefrontal cortex (Brod-
mann’s area 46) was obtained from the Stanley Medical
Research Institute (http://sncid.stanleyresearch.org/) (Kim
andWebster2009,2010).Brainsamplesweretakenfrom35
schizophrenics (26 males, 9 females; mean ± SD age,
42.6 ± 8.5 years; postmortem interval (PMI), 31.4 ±
15.5 h;brainpH,6.5 ± 0.2),35bipolardisorderpatients(17
males, 18 females; mean ± SD age, 45.3 ± 10.5 years;
PMI, 37.9 ± 18.3 h; brain pH, 6.4 ± 0.3), and 35 controls
(26 males, 9 females; mean ± SD age, 44.2 ± 7.6 years;
PMI, 29.4 ± 12.9 h; brain pH, 6.6 ± 0.3). Diagnoses were
made in accordance with DSM-IV criteria. There were no
signiﬁcant demographic differences between the schizo-
phrenia,bipolar disorder,andcontrolbrains, intermsofage,
PMI,andsamplepH.Allthepatientswithschizophreniaand
bipolardisorderhadpreviouslyreceivedtherapeuticdrugsto
treat their disease.
Gene-centric association study
SNP information was based on the UCSC database
(http://genome.ucsc.edu/). UsingldSelectsoftware(Carlson
et al. 2004), tag SNPs were selected according to the fol-
lowing criteria: alleles captured with r
2 C 0.8 and minor
allele frequency (MAF) C 10% in the Han Chinese popu-
lation.Inthegene-centricassociationstudy,SNPgenotyping
was performed using the TaqMan system (Applied Biosys-
tems, Foster City, CA, USA), following the manufacturer’s
recommendation. PCR was performed using an ABI 9700
thermocycler, and ﬂuorescent signals were analyzed on an
ABI 7900HT Fast real-time PCR System using Sequence
Detection Software (SDS) v2.3 (Applied Biosystems).
Linkage disequilibrium (LD) between markers and
departures from the assumption of Hardy–Weinberg equi-
librium (HWE) were evaluated based on data from inde-
pendent parents.
Brain tissue and quantitative RT-PCR
Real-time quantitative RT-PCR analysis was conducted using
an ABI7900HT Fast Real-Time PCR System (Applied Bio-
systems).TaqManprobesandprimersforKCNJ3andGAPDH
(an internal control) were Assay-on-Demand
TM or Assay-by-
Design
TMgeneexpressionproducts(AppliedBiosystems).All
real-time quantitative RT-PCR reactions were performed in
triplicate, based on the standard curve method.
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The exons of KCNJ3 were screened for genomic variants
by direct sequencing of PCR products, using 58 unrelated
Chinese schizophrenia samples. Information on the primers
and conditions for ampliﬁcation are available upon request.
Direct sequencing of PCR products was performed using
the BigDye Terminator Cycle Sequencing FS Ready
Reaction kit (Applied Biosystems) and the ABI PRISM
3730xl DNA Analyzer (Applied Biosystems). SNPs were
detected using the SEQUENCHER program (Gene Codes
Corporation, Ann Arbor, MI, USA).
Statistical analyses
The degree of LD between all SNP markers was evaluated
and haplotype structures were constructed using HAPLO-
VIEW, version 4.2 (Barrett et al. 2005). Single SNP and
haplotype association tests were conducted using UNPH-
ASED, version 2.404 (Dudbridge 2008). For multiple
testing corrections, the permutations were generated by
randomizing the transmission status of the parental haplo-
types. In each permutation, the minimum P value was
compared to the minimum P value over all the analyses in
the original data. This allows for multiple testing correc-
tions over all tests performed in a run (Dudbridge 2008).
The Mann–Whitney U test (two-tailed) was used to
evaluate changes in gene expression levels between control
and disease groups.
Results
Association study of NIMH Chinese family samples
To examine association of the KCNJ3 gene with schizo-
phrenia in the Chinese population, we performed a family-
based association study, by genotyping 293 pedigree
samples (284 quad and 9 trio samples, consisting of 1,163
family members) of Chinese origin.
Based on the HapMap database (http://hapmap.ncbi.
nlm.nih.gov/), 37 tagSNPs were selected and successfully
genotyped in the Chinese pedigree sample (Table 1). The
SNP, rs5835552, detected in our mutation screening was
also genotyped. Therefore, we analyzed a total of 38 SNPs.
Single marker analysis revealed strong associations for
rs3106658 (P = 0.0016) and rs3106651 (P = 0.0019)
(Table 1). These SNPs are located in an intronic region
approximately 1.7 and 12.4 kb downstream of exon 2
(Fig. 1). The initial marker rs3106653, which showed
genetic association with disease in Japanese samples was
also signiﬁcant in the Chinese population (P = 0.029)
(Table 1). The remaining six SNPs (rs3111037, rs1823002,
rs2652443, rs4567888, rs6713287 and rs 1037091) showed
nominally signiﬁcant allelic association with disease
(Table 1). Signiﬁcant SNPs in the gene showed no
Table 1 SNP information
dbSNP
a Position
b Allele
c P value
d
rs4571015 155545670 G/T 0.0522
rs3111037 155548559 A/C 0.0339
rs3106658 155568062 A/G 0.0016
rs11895478 155571123 C/T 0.0684
rs3106653 155575560 A/C 0.0289
rs3106652 155578422 C/T 0.2100
rs3106651 155578779 C/T 0.0019
rs11895336 155585934 C/T 0.2109
rs3113007 155592410 A/G 0.4855
rs12471193 155596137 A/G 0.1278
rs6711727 155596438 A/G 0.1374
rs1823002 155605132 A/G 0.0413
rs2652443 155605737 A/G 0.0101
rs2121085 155607465 A/G 0.0892
rs2121089 155609387 A/C 0.0561
rs1992701 155609638 C/T 0.4310
rs16838098 155612020 A/G 0.2591
rs2921436 155615006 C/G 0.1121
rs2921440 155616886 A/G 0.8137
rs4567888 155622752 A/T 0.0312
rs985092 155629561 A/G 0.3705
rs985535 155632935 A/G 1.0000
rs11899272 155634578 C/T 0.5525
rs6713287 155635168 A/T 0.0280
rs16838151 155636504 A/G 0.0956
rs13398937 155640347 C/G 0.5371
rs2053672 155643978 C/G 0.6419
rs12616121 155645682 A/G 0.8597
rs2591157 155648366 A/G 0.4245
rs1838674 155651541 A/G 0.1443
rs1037091 155652357 A/G 0.0406
rs1445654 155653558 A/T 0.2041
rs2961976 155654466 G/T 0.8658
rs2591152 155656952 A/C 0.4419
rs1445649 155682556 A/G 0.2632
rs2971902 155692378 G/T 0.1191
rs13030348 155695054 C/T 0.5076
rs5835552 155712135–155712136 (-/T) 0.4829
a Data taken from the NCBI database (http://www.ncbi.nlm.nih.gov/
projects/SNP/)
b,c The SNP positions and allele designations are from the UCSC Gen-
ome Browser on Human Feb. 2009 (GRCh37/hg19) Assembly (dbSNP
build 132) (http://genome.ucsc.edu/cgi-bin/hgGateway). The overtrans-
mittedallelesareshowninbold.Forrs2961976,bothalleleswereequally
transmittedtothepatients.Forrs5835552,(–)allelewasovertransmitted
d P values of\0.05 are indicated in bold and italic
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123deviation from Hardy–Weinberg disequilibrium in the
samples (independent parents of families).
Correction for multiple testing was conducted using the
permutation method. This procedure gave a global signi-
ﬁcance level of P = 0.036 after 10,000 permutations
[standard error (SE) = 0.00186].
Analysis of haplotype structures by the conﬁdence
interval method (Gabriel et al. 2002) identiﬁed eight hap-
lotype blocks in the region (Fig. 2). We performed haplo-
typic tests for association (Supplementary Table S1). Three
of the eight haplotype blocks showed signiﬁcant associa-
tion with disease (global P = 0.0067, 0.026 and 0.0386).
The two most strongly associated SNPs (rs3106658 and
rs3106651) were both located in haplotype block 2, how-
ever, most of the other signiﬁcant SNPs were not in sub-
stantial LD to each other.
Real-time quantitative RT-PCR analysis in postmortem
brains
The identiﬁcation of KCNJ3 as a susceptibility gene for
schizophrenia led us to examine whether there was altered
gene expression in the postmortem brains of patients. Real-
time quantitative RT-PCR experiments showed that
KCNJ3 was down-regulated in the prefrontal cortex of
schizophrenic and bipolar disorder patients, compared with
controls (Fig. 3). To evaluate the effects of medication,
Spearman rank-correlation coefﬁcient was used to examine
the relation between gene expression levels and a total
lifetime exposure to the antipsychotic drug. The transcript
levels were not correlated with lifetime use of antipsy-
chotic drugs (P = 0.647 for schizophrenia, P = 0.608 for
bipolar disorder patients).
Resequencing of the KCNJ3 gene
To screen for possible functional or causative variants of
the KCNJ3 gene, we resequenced all exons using 58
independent samples derived from schizophrenics. We
found two novel and ﬁve known variants on or close to
the upstream and downstream regions of the gene
(Supplementary Fig. S1). No nonsynonymous SNPs were
detected. Six of seven SNPs showed low allele fre-
quencies (\6.2%) (Supplementary Fig. S1). Given the
rarity of these variants, they were excluded from further
analysis. The common SNP, rs5835552, was included in
KCNJ3
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Fig. 1 Genomic structure of KCNJ3 and gene-centric association
analysis. In the upper panel, genomic structure and locations of
examined tagSNPs in and around KCNJ3 are shown, with chromo-
somal positions marked according to the human genome database
(http://genome.ucsc.edu/) on the top. Gene exons are denoted by
boxes. White boxes show non-coding regions. In the lower panel, the
negative logarithm of P value for association is plotted as a function
of chromosomal positions of SNP markers. Horizontal bold line
indicates P value = 0.05 and 0.01
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123the gene-based association study as stated above (not
signiﬁcant).
Discussion
In this study, we conducted a gene-based replication study
for a novel candidate gene, KCNJ3 identiﬁed from our
prior GWAS in Japanese samples (Yamada et al. 2011),
using a Han Chinese sample. We genotyped SNPs and
resequenced exonic sequences to identify risk variants for
schizophrenia. This approach allowed for greater coverage
of genetic variations with the additional advantage of
narrowing down regions relevant to functional variants,
although in this case, we did not identify truly causative
SNPs.
Single SNPs and haplotypic analyses have provided
genetic evidence for the association of KCNJ3 with
schizophrenia in Chinese cohorts. Interestingly, the sig-
niﬁcant SNP markers and haplotypes were substantially not
overlapped. This observation suggests a genetic evidence
of allelic heterogeneity for disease risk spanning the
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were constructed using HAPLOVIEW, version 4.2 (http://www.
broadinstitute.org/scientiﬁc-community/science/programs/medical-
and-population-genetics/haploview/haploview). The global signiﬁ-
cance levels shown, were calculated using PDTPHASE implemented
in the UNPHASED program version 2.404 (http://www.mrc-bsu.
cam.ac.uk/personal/frank/software/unphased/) (Dudbridge 2008). Values
in the box show the squared correlation coefﬁcient (r
2) between the
SNPs. Signiﬁcant SNPs and haplotype blocks are shown in red
(P\0.05). Haplotype blocks 2, 4 and 5 showed signiﬁcant haplo-
typic association with schizophrenia
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Fig. 3 Real-time quantitative RT-PCR analysis of the KCNJ3 gene in
postmortem brains. Rectangles and triangles represent individual
samples. Horizontal bars delineate the mean of each group. The
expression levels of KCNJ3 were signiﬁcantly decreased in the
dorsolateral prefrontal cortex of postmortem brains from schizo-
phrenics and bipolar disorder patients, compared with controls
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were reduced in the prefrontal cortex of postmortem brains
from schizophrenic and bipolar patients. We also per-
formed genotyping of eight SNPs that are on the annotated
genes among the top 20 signals (Yamada et al. 2011),
however, these SNPs have failed to support association in
Chinese population (Supplementary Table S2).
The KCNJ3 gene is a novel candidate in schizophrenia
genetics. The gene encodes a G protein-activated, inwardly
rectifying potassium channel (GIRK1/Kir3.1) and belongs
to the Kir3.x subfamily of inwardly rectifying potassium
channels. Inwardly rectifying potassium channels are
classiﬁed into seven subfamilies (Kir1.x to Kir7.x) and
categorized into four functional groups (K
? transport
channels, classical Kir channels, G protein-activated K
?
channels and ATP-sensitive K
? channels). Four genes,
KCNJ3, KCNJ6, KCNJ9 and KCNJ5, are included in the
GIRK channel group (also termed GIRK1–GIRK4 or
Kir3.1–Kir3.4, respectively) (Hibino et al. 2010). GIRK
channels play an important role in maintaining resting
membrane potential and regulating the duration of action
potentials (Hille 1992).
GIRK1 generally exist as heteromers with other GIRK
subunits to form GIRK channels in native cells and tissues.
The subunit composition of GIRK channels varies among
different cells and tissues, allowing them to play diverse
functional roles. In the central nervous system, neuronal
GIRK channels are mostly heterotetramers of GIRK1 and
GIRK2 subunits (Inanobe et al. 1999; Jelacic et al. 2000;
Kofuji et al. 1995; Krapivinsky et al. 1995; Lesage et al.
1995;Liaoetal.1996;Yamadaetal.1998).Theactivationof
GIRKchannelsbydirectbindingoftheintracellulareffector
molecules, Gbc, results in channel opening. This channel
opening hyperpolarizes cells, reducing neuronal excitability
in many central neurons (Clapham and Neer 1993; Dascal
1997; Jan and Jan 1997; Logothetis et al. 2007; Sadja et al.
2003; Yamada et al. 1998). Many GPCRs in the central
nervous system, including the receptors for somatostatin,
5-hydroxytryptamine (5HTR1), norepinephrine (ADRA2A,
ADRA2B and ADRA2C), l- (OPRM1), d-opioid (OPRD1),
dopamine (DRD2), glutamate (GRM1 to 8), cannabinoid
(CNR1 and CNR2) and GABA (GABBR1 and 2) use signal
transduction mechanisms through GIRK channels. These
receptors are implicated in a variety of human disorders
including schizophrenia (Karam et al. 2010).
These channels may contribute to a range of behaviors,
anxiety, spasticity, pain and reward. GIRK1 and 2 knock-
out mice (GIRK1
-/-/GIRK2
-/-) are viable and appear
normal, but they exhibit thermal hyperalgesia in the tail-
ﬂick test and display decreased analgesic responses, fol-
lowing intrathecal administration of morphine (Marker
et al. 2004). In addition, GIRK1
-/- mice display elevated
open-ﬁeld activity, decreased anxiety-like behavior,
decreased baclofen ataxia and increased operant respond-
ing for food (Pravetoni and Wickman 2008).
Synaptic N-methyl-D-aspartate (NMDA) receptor acti-
vation in cultured hippocampal neurons increases surface
expression of GIRK1 and GIRK2 subunits in the soma,
dendrites, and dendritic spines (Chung et al. 2009a, b).
Conversely, NMDA receptor antagonists inhibit GIRK
complex formation (Kobayashi et al. 2006). In this study,
real-time quantitative RT-PCR experiments showed that
KCNJ3 is down-regulated in the prefrontal cortex of
schizophrenic patients. This ﬁnding may lend support to
the ‘‘hypo-NMDA theory of schizophrenia’’. Recent stud-
ies suggest a genetic association between neuregulin-erbB
receptor signaling and schizophrenia (Pitcher et al. 2011;
Stefansson et al. 2002), and a functional link between
neuregulin-erbB receptor signaling and GIRK is also
reported (Ford et al. 2003).
Genetic studies raise the possibility that schizophrenia
shares genetic risk factors with other psychiatric disorders
(Cascella et al. 2009; Crespi et al. 2010; Rzhetsky et al.
2007). In this study, decreased gene expression was
observed in the brains from bipolar disorder, as well as
schizophrenia patients. For mood disorders, chronic
administration of the selective serotonin reuptake inhibitor,
ﬂuoxetine, exerts a beneﬁcial effect on a rodent model of
depression, through suppression of GIRK-dependent sig-
naling (Cornelisse et al. 2007). In addition, acute inhibition
of GIRK channels by ﬂuoxetine causes substantial sup-
pression of neuronal cell death in mice with mutant GIRK
channels (Takahashi et al. 2006). Interestingly, the KCNJ3
gene lies in one of only two regions to have achieved
genome-wide signiﬁcance for linkage in autism (Consor-
tium IMGSoA 2001). Recently, molecular cytogenetic
characterization of two unrelated patients with 2q dele-
tions, both of whom are affected by developmental delays
with communication impairment, and one of whom has a
diagnosis of autistic spectrum disorder, revealed that
KCNJ3 is the only gene located within the overlapping
region of the two deletions (Newbury et al. 2009). In epi-
lepsy, SNP, rs17642086 (1038T[C, His346His) in KCNJ3
shows positive association with idiopathic generalized
epilepsy (P = 0.0097) (Chioza et al. 2002). However, this
SNP was in weak LD with our signiﬁcant SNPs on KCNJ3,
and we found no genetic association between this SNP and
our schizophrenia samples (P = 0.816).
Copy number variants (CNVs) are emerging as an
important genomic cause of neuropsychiatric disorders
(Coyle 2009). In addition, altered microRNA (miRNA)
expression proﬁles are suggested in the pathogenesis of
schizophrenia (Merikangas et al. 2009; Stankiewicz and
Lupski 2010). The region does not contain any known
CNVs according to a database (Database of Genomic
Variants: http://projects.tcag.ca/variation/). By contrast,
448 Hum Genet (2012) 131:443–451
123ﬁve conserved sites for miRNA families are detected by the
TagetScanHuman (Release 5.2: June 2011, http://www.
targetscan.org/) and there are 131 potential miRNA target
sites in the gene region (miRNAMAP: http://mirnamap.
mbc.nctu.edu.tw/). Therefore, the roles of miRNAs in the
gene expression levels need further scrutiny.
In conclusion, we have provided evidence that KCNJ3
contributes to schizophrenia in Asian populations, adding
another susceptibility candidate gene to the ‘‘channelopa-
thy theory of psychiatric illnesses’’. Our ﬁndings suggest a
signiﬁcant but a modest association between schizophrenia
and the KCNJ3 gene. Thus, future studies with a much
larger sample size in Asian and/or in other ethnicities are
needed to conﬁrm the genetic contribution of the gene for
schizophrenia. Moreover, genetic studies on channel genes
including genes in potassium channels are warranted to
improve the understanding of schizophrenia pathogenesis.
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